Endothelial progenitor cells as an angiogenic biomarker for the diagnosis and prognosis of lung cancer.

Journal: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
Published Date: Dec 4, 2024

Abstract

BACKGROUND: Angiogenesis is mediated by endothelial progenitor cells (EPCs) derived from bone-marrow. In this prospective study, we tried to investigate the clinical utility of circulating EPCs in lung cancer (LC) patients.

Authors

  • Fadi Najjar
    Biomarkers Laboratory, Department of Radiation Medicine, Atomic Energy Commission of Syria (AECS), Damascus, Syria.
  • Hassan Alsabe
    Division of Thoracic Oncology, Department of Oncology, Al-Bairouni University Hospital, Damascus, Syria.
  • Hussein Sabbagh
    Division of Thoracic Oncology, Department of Oncology, Al-Bairouni University Hospital, Damascus, Syria.
  • Ghassan Al-Massarani
    Biomarkers Laboratory, Department of Radiation Medicine, Atomic Energy Commission of Syria (AECS), Damascus, Syria.
  • Abdulmunim Aljapawe
    Radiobiology Laboratory, Department of Molecular Biology and Biotechnology, Atomic Energy Commission (AEC), Damascus, Syria.
  • Nissreen Alamalla
    Biomarkers Laboratory, Department of Radiation Medicine, Atomic Energy Commission of Syria (AECS), Damascus, Syria.
  • Issraa Banat
    Biomarkers Laboratory, Department of Radiation Medicine, Atomic Energy Commission of Syria (AECS), Damascus, Syria.
  • Adnan Ikhtiar
    Radiobiology Laboratory, Department of Molecular Biology and Biotechnology, Atomic Energy Commission (AEC), Damascus, Syria.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals